Daraxonrasib is poised to become the new standard of care for previously treated metastatic pancreatic cancer after detailed results from a Phase III clinical trial were released at the American ...

At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...

The Higher Education Commission (HEC) is facing criticism from applicants over its recently introduced digital degree attestation system, with users reporting delays, technical issues and difficulties ...

RAS mutations are among the most common drivers in cancer, particularly in pancreatic, colorectal, and lung tumors. Despite that, directly targeting RAS proteins proved extremely difficult for years, ...

Nahda Nabiilah is a writer and editor from Indonesia. She has always loved writing and playing games, so one day she decided to combine the two. Most of the time, writing gaming guides is a blast for ...

Getting a depth module in Subnautica 2 increases your tadpole submarine's depth resistance and lets you explore further without having to worry about finding oxygen spots. However, you'll reach the ...

The targeted RAS inhibitor daraxonrasib was found to be safe and showed signs of efficacy in patients with previously treated RAS-mutant metastatic pancreatic cancer, according to a Phase I/II ...

The Tampa Bay Buccaneers walked away from the 2026 NFL Draft with a strong class, adding a few potential starters and depth pieces for the future. That class also comes with a notable theme, and it ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Rachel Wharton Rachel Wharton is a writer covering kitchen appliances. For ...

The United States applies defense-in-depth as a foundational principle in nuclear deterrence, missile defense, cyber architecture, and critical infrastructure protection. In each of these domains, the ...

PARIS — RAS Luxury Skincare, the Indian farm-to-face brand, closed a 65 Crores, or $7.5 million, Series B funding round led by Dabur Ventures. Dabur Ventures is the venture arm of the largest ...